Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Veronica Olivo Pimentel, Damiënne Marcus, Alexander MA van der Wiel, Natasja G Lieuwes, Rianne Biemans, Relinde IY Lieverse, Dario Neri, Jan Theys, Ala Yaromina, Ludwig J Dubois, Philippe Lambin

Journal title: Journal for ImmunoTherapy of Cancer

Journal number: 9/3

Journal publisher: BMJ

Published year: 2021

Published pages: e001764

DOI identifier: 10.1136/jitc-2020-001764

ISSN: 2051-1426